UNIGE document Scientific Article
previous document  unige:108532  next document
add to browser collection

A new bioinformatics tool to help assess the significance of BRCA1 variants

Authors show hidden authors show all authors [1 - 10]
Published in Human genomics. 2018, vol. 12, no. 1, 36
Abstract Germline pathogenic variants in the breast cancer type 1 susceptibility gene BRCA1 are associated with a 60% lifetime risk for breast and ovarian cancer. This overall risk estimate is for all BRCA1 variants; obviously, not all variants confer the same risk of developing a disease. In cancer patients, loss of BRCA1 function in tumor tissue has been associated with an increased sensitivity to platinum agents and to poly-(ADP-ribose) polymerase (PARP) inhibitors. For clinical management of both at-risk individuals and cancer patients, it would be important that each identified genetic variant be associated with clinical significance. Unfortunately for the vast majority of variants, the clinical impact is unknown. The availability of results from studies assessing the impact of variants on protein function may provide insight of crucial importance.
PMID: 29996917
Full text
Article (Published version) (1.2 MB) - public document Free access
Research group Calipho (80)
(ISO format)
CUSIN, Isabelle et al. A new bioinformatics tool to help assess the significance of BRCA1 variants. In: Human Genomics, 2018, vol. 12, n° 1, p. 36. doi: 10.1186/s40246-018-0168-0 https://archive-ouverte.unige.ch/unige:108532

367 hits



Deposited on : 2018-09-26

Export document
Format :
Citation style :